Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of diazepam and pethidine is used primarily for pain management and sedation, particularly during medical procedures. This combination leverages the anxiolytic and muscle relaxant properties of diazepam with the analgesic effects of pethidine. ## Pharmacology and Mechanism of Action Diazepam is a benzodiazepine that works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits brain activity. It produces a calming effect on the brain and nerves, which helps prevent seizures, reduce anxiety symptoms, and relax muscles. Pethidine (meperidine) is an opioid analgesic that binds to opioid receptors in the brain and spinal cord, reducing the perception of pain and producing sedation. When combined, these medications provide both pain relief and sedation, making them useful for procedures that may cause discomfort or anxiety. ## Clinical Applications The combination of diazepam and pethidine has been shown to be effective for: - Pain control during medical procedures, particularly extracorporeal shock wave lithotripsy (ESWL) - Sedation for invasive procedures - Management of acute pain with associated anxiety A study comparing this combination to diclofenac sodium plus hyoscine-N-butyl bromide found that pethidine with diazepam provided superior pain control during ESWL procedures. ## Safety Concerns The FDA has issued strong warnings about combining opioids (such as pethidine) with benzodiazepines (such as diazepam) due to serious risks including: - Slowed or difficult breathing - Sedation - Potential for coma - Increased risk of death Due to these concerns, the FDA has added Boxed Warnings (their strongest warning) to the labeling of prescription opioid pain medicines and benzodiazepines. ## Dosing Considerations Dosing must be carefully determined on an individual basis, considering: - The condition being treated - Severity of symptoms - Patient body weight - Other conditions the person may have The combination should be used under close medical supervision due to the potential for respiratory depression and other serious side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diazepam and pethidine combination.